Posted in:News FDA Accepts BLA from Mylan and Biocon for Pegfilgrastim Biosimilar By C. Nichole Gifford February 16, 2017 Comments are off The FDA has accepted for review an application submitted by Mylan N.V. (“Mylan”) and Biocon Ltd. (“Biocon”) under the 351(k)... Read more Tagged with: Biocon, FDA, Mylan, Neulasta®, News, pegfilgrastim, Regulatory, Roche http://twitter.com/share?text="[TITLE]&url=[PERMALINK]ShareEmail, Linked In, Twitter, Facebook, Google Plus